ENTITY

Denali Therapeutics (DNLI US)

Analysis

Health Care • United States

Denali Therapeutics Inc. operates as a biotechnology company. The Company discovers and develops medicines for neurodegenerative diseases. Denali Therapeutics serves patients in the State of California.

Refresh

Focused

No publications yet

Add Denali Therapeutics to your Watchlist to get alerts on new publications

Add to Watchlist

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00